34
Participants
Start Date
November 30, 2015
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
RELiZORB
Peptamen 1.5 received Period A and Period B (washout only). Impact Peptide 1.5 received Period B (Days 1 and 9 only) and Period C.
Placebo
Sham device
Children's Hospital of Pittsburgh, Pittsburgh
Monroe Carell Junior Children's Hospital at Vanderbilt, Nashville
Nationwide Children's Hospital, Columbus
Rainbow Babies and Children's Hospital, Cleveland
Riley Hospital for Children at Indiana University Health, Indianapolis
Children's Hospital of Wisconsin, Milwaukee
Cardinal Glennon Children's Medical Center, St Louis
Children's Mercy Hospital, Kansas City
St. Luke's Cystic Fibrosis Center of Idaho, Boise
Children's Hospital of Los Angeles, Los Angeles
Maine Medical Center, Portland
Lead Sponsor
Alcresta Therapeutics, Inc.
INDUSTRY